Imperva Inc (NYSE:IMPV) will release its earnings data after the market closes on Wednesday, November 1st. Analysts expect Imperva to post earnings of $0.22 per share for the quarter. Imperva has set its Q3 guidance at $0.22-0.26 EPS and its FY17 guidance at $0.78-0.82 EPS.

Imperva (NYSE:IMPV) last announced its earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.15). The business had revenue of $74.44 million for the quarter, compared to analysts’ expectations of $74.30 million. Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The firm’s quarterly revenue was up 28.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.23) earnings per share. On average, analysts expect Imperva to post $0.85 EPS for the current fiscal year and $0.96 EPS for the next fiscal year.

Shares of Imperva Inc (IMPV) opened at 43.50 on Wednesday. The stock’s market capitalization is $1.47 billion. The stock’s 50 day moving average is $43.75 and its 200 day moving average is $45.97. Imperva Inc has a 12 month low of $34.40 and a 12 month high of $52.40.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/25/imperva-inc-impv-to-release-earnings-on-wednesday.html.

IMPV has been the topic of several research reports. BidaskClub downgraded shares of Imperva from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 5th. ValuEngine downgraded shares of Imperva from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Stephens reissued an “overweight” rating and issued a $61.00 price target (up from $53.00) on shares of Imperva in a research note on Thursday, July 13th. Stifel Nicolaus reissued a “hold” rating and issued a $47.00 price target on shares of Imperva in a research note on Friday, July 14th. Finally, Evercore ISI set a $56.00 price target on shares of Imperva and gave the stock a “buy” rating in a research note on Friday, July 28th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $51.23.

In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of Imperva stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the transaction, the director now directly owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.20% of the stock is owned by insiders.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Earnings History for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.